ClinicalTrialsFinder
RecruitingNot ApplicableNCT06688825

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

Sponsor

Virginia Commonwealth University

Enrollment

30 participants

Start Date

Sep 16, 2024

Study Type

INTERVENTIONAL

Conditions

ObesityKidney Transplant; Complications

Summary

This project will be a single-arm feasibility study, with a treatment intervention that includes three interrelated components: (1) patient education using a proven weight loss curriculum, and (2) technology tools for making healthy lifestyle choices.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Blood draw, a behavioral approach called Education regarding Weight loss, and others for people with kidney transplant; complications and obesity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEducation regarding Weight loss

Per American Association of Clinical Endocrinology (AACE) guidelines

BEHAVIORALLifestyle tools for weight loss

Calorie App, Continuous GlucosWe Monitor (CGM), Weight Scale, Food Scale

BIOLOGICALBlood draw

Per American Association of Clinical Endocrinology (AACE) guidelines

Locations(1)

Virginia Commonwealth University

Richmond, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06688825

Related Trials

A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight

NCT076932313 locations

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

NCT055615951 location

A Study to Evaluate ALN-6222 in Participants With Obesity

NCT076240711 location

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

NCT0749788033 locations

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433782 locations